We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App




New Robotic System Automates Clinical Flow Cytometry Diagnostics

By LabMedica International staff writers
Posted on 14 Jun 2023

Flow cytometry analyzes a population of cells on a cell-by-cell basis, an essential feature for researchers and clinicians aiming to identify specific cells within a sample for disease or biological process studies. More...

This technique is not only extraordinarily rapid, but it also enables the simultaneous measurement of multiple attributes of single cells, a process known as multiplexing. These benefits have transformed flow cytometry into a versatile tool for both researchers and clinicians, making it a critical instrument for clinical diagnostics, especially in diagnosing and managing diseases like cancer. Now, a new automated instrument that prepares samples for clinical diagnostics using flow cytometry offers a full "walkaway" workflow solution to enhance standardization and reproducibility in cellular diagnostics.

BD (Becton, Dickinson and Company, Franklin Lakes, NJ, USA) has launched the new BD FACSDuet Premium Sample Preparation System globally. This system employs liquid-handling robotics to fully automate the sample preparation process for both in vitro diagnostics (IVD) and user-defined tests. It handles tasks such as cocktailing, washing, and centrifuging, and then automatically transfers samples to the physically integrated BD FACSLyric Clinical Flow Cytometry System, eliminating the need for human intervention. Thanks to its integration with the flow cytometer, the BD FACSDuet Premium System offers a "walkaway" workflow solution that cuts down manual steps, resources, and user hands-on time compared to previous solutions.

"Our clinical customers have long trusted BD and our best-in-class products to standardize every step of the clinical lab workflow – from panel creation to sample preparation to analysis to report," said Steve Conly, worldwide president, BD Biosciences. "The flagship BD FACSLyric Flow Cytometry System is one of the fastest adopted clinical instruments in the world and now together with the FACSDuet Premium System, which has achieved IVD status in the U.S. and Europe, we usher in greater levels of automation so that our customers can focus more of their valuable time on analyzing and interpreting samples and impacting outcomes."

Related Links:
BD


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Procalcitonin Test
LIAISON B•R•A•H•M•S PCT II GEN
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: Microscope image showing human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color (Photo courtesy of Fred Hutch Cancer Center)

Mouth Bacteria Test Could Predict Colon Cancer Progression

Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more

Pathology

view channel
Image: A new study has identified patterns that predict ovarian cancer relapse (Photo courtesy of Cedars-Sinai)

Spatial Tissue Analysis Identifies Patterns Associated With Ovarian Cancer Relapse

High-grade serous ovarian carcinoma is the most lethal type of ovarian cancer, and it poses significant detection challenges. Typically, patients initially respond to surgery and chemotherapy, but the... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.